A new app for mobile phones that provides localized information on ultraviolet (UV) radiation levels has been created by the World Health Organization (WHO), the United Nations Environment Programme (UNEP), the World Meteorological Organization, and the International Labour Organization (ILO).  The app is available free of charge on both the Apple App and Google Play […] Continue reading ->
The high rate of smokeless tobacco consumption especially in low-and middle income countries is a looming global public health challenge. The unregulated sale of these products especially in South and South-East Asia has underscored the need to revamp the national regulations, according to the Seventh Edition of the Tobacco Atlas published Wednesday.  The report  by […] Continue reading ->
Almost two-thirds of adults and a third of children are overweight or obese in the World Health Organization (WHO) European Region and this is driving cancer and other diseases, according to the WHO European Regional Obesity Report 2022 report released on Tuesday. The highest prevalence is in Turkey, Malta, Israel and the UK (WHO Europe […] Continue reading ->
Nearly ten years of air pollution data for dozens of Indian cities – among the most polluted in the world – was deleted from the latest World Health Organization Air Quality database just before WHO published the report on 4 April 2022, Health Policy Watch has learned.  The Indian air quality data, spanning the years […] Continue reading ->
In its largest release of data on air quality ever, WHO has found that most of the world’s population are breathing unsafe levels of air pollutant – particularly fine particulate matter (PM2.5)  and Nitrogen dioxide (NO2) – which cause excess illness and premature death from respiratory disease, as well as from cardiovascular disease and cancers.  […] Continue reading ->
South Africa’s Competition Commission is pursuing prosecution against Swiss pharmaceutical giant Roche for “alleged excessive pricing” of its breast cancer treatment drug, Trastuzumab (marketed as Herceptin). It estimates that some 10,000 women were unable to get the treatment they needed between 2011 and 2019 because of Trastuzumab’s cost. It has asked the country’s Competition Tribunal […] Continue reading ->